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ABSTRACT
Introduction: Evidence of patients’ experiences is
fundamental to creating effective health policy and
service responses, yet is missing from our
knowledge of adverse events. This protocol describes
explorative research redressing this significant deficit;
investigating the experiences of a large cohort of
recently hospitalised patients aged 45 years and
above in hospitals in New South Wales (NSW),
Australia.
Methods and analysis: The 45 and Up Study is a
cohort of 265 000 adults aged 45 years and above
in NSW. Patients who were hospitalised between 1
January and 30 June 2014 will be identified from
this cohort using data linkage and a random sample
of 20 000 invited to participate. A cross-sectional
survey (including qualitative and quantitative
components) will capture patients’ experiences in
hospital and specifically of adverse events.
Approximately 25% of respondents are likely to
report experiencing an adverse event. Quantitative
components will capture the nature and type of
events as well as common features of patients’
experiences. Qualitative data provide contextual
knowledge of their condition and care and the
impact of the event on individuals. Respondents
who do not report an adverse event will report their
experience in hospital and be the control group.
Statistical and thematic analysis will be used to
present a patient perspective of their experiences in
hospital; the characteristics of patients experiencing
an adverse event; experiences of information
sharing after an event (open disclosure) and the
other avenues of redress pursued. Interviews
with key policymakers and a document analysis
will be used to create a map of the current
practice.
Ethics and dissemination: Dissemination via a
one-day workshop, peer-reviewed publications and
conference presentations will enable effective clinical
responses and service provision and policy
responses to adverse events to be developed.
BACKGROUND
Adverse events are a significant problem
Preventable harm in hospitals due to health-
care activities is one of the top six health pro-
blems in the developed world.1 At least one
in nine hospitalised patients suffer an
adverse event (AE) which may require extra-
care or cause permanent harm or even
death.2 It is estimated that AEs add 13–16%
to hospital costs alone—at least one dollar
in every seven spent on healthcare.3 This
Strengths and limitations of this study
▪ The use of data linkage is a novel strategy that
will facilitate identification of a large number of
recently hospitalised patients; patient experience
studies to date consistently suffer from small
and unrepresentative patient samples.
▪ Linkage with admitted patient data allows us to
triangulate patient reported experiences with
information in their medical record for example,
the health problem they presented with, how
long they were in hospital and the treatments
received; this information validates the self-
reported patient data.
▪ The 45 and Up Study cohort does not include a
representative sample of culturally and linguistic-
ally diverse (CALD) participants. We address this
weakness by analysing a subsample of data of
CALD participants to explore whether their
experiences differ from the wider sample.
▪ The patient sample only includes those who are
45 years or older therefore is not a representative
population sample. Adults aged 45 and above
are more likely to be hospitalised and have more
frequent contact with the health system; there-
fore knowledge of the experiences of this group
is valuable. Data from younger patients may be
explored in future work using this study as a
model.
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ﬁgure does not include human costs such as pain and
suffering or loss of independence and productivity for
patients and their carers, or costs of litigation and settle-
ment of medical negligence claims. Measurable and sus-
tainable improvements in quality and safety are yet to be
realised.4
Patient symptoms are often indicators of the amount
of harm arising from healthcare,1 with retrospective
medical record review studies detailing a large rate of
errors of commission and omission; many causing
AEs.5 6 While a very low percentage of patients with AEs
initiate a formal complaint, signiﬁcant numbers (23–
50%) report concerns related to an AE or undesirable
events.7–11 Complaints from patients may have prompted
the initial scrutiny of safety in healthcare, but patients
have been largely ignored as a source of safety evidence
or measurement and are rarely involved in reporting
AEs outside symptoms.4 5 12
Little is known about the impact of AEs on patients
Health systems rely on patient experiences as a central
and integral source of knowledge of health issues, policy
development and service planning for almost all aspects
of healthcare, yet we know little of their experiences,
which remain largely absent from any input into better
understanding the nature of AEs. Models of the impact
of AEs on patients are lacking due to lack of research.
Evidence-based models generated from patient reported
data regarding the types of harm that patients experi-
ence is urgently required as these are the patient groups
most vulnerable to harm.
Knowing and understanding patients’ experiences of
AEs is crucial for creating and maintaining trust in their
health providers and in the health system.13–16 Patient
experience data of AEs will also contribute to under-
standing the patient populations such as older patients
who may be at a greater risk of AEs or of negative seque-
lae from AEs.17–19 These data will provide insight into
AEs that occur after discharge (eg, infection); some
postdischarge AEs are also believed to be due to deﬁ-
cient handover of information but data are limited.20–22
Finally, patient experience data will contribute to under-
standing the association between an AE and patients’
subsequent health needs (eg, requiring hospitalisation),
which has not been explored.23
AE reporting in Australia
All Australian states and territories have active incident
reporting systems; in 2007 the Australian state of New
South Wales (NSW) implemented the Incident
Information Management System (IIMS). This system
records data reports on ‘incidents’ (including AEs along
with other untoward incidents such as accidents or
thefts) and after analysis are reported annually. The rela-
tionship between error and harm in healthcare is
complex and the focus in these systems on encouraging
staff to report errors or ‘incidents’ is limiting.24 Most
reported errors are errors of commission, although
chart reviews suggest that acts of omission are implicated
in twice as many AEs.9 25 There are signiﬁcant levels of
under-reporting in current voluntary reporting systems.
(ref. 26, p.56) Doctors, for example, rarely report using
incident reporting systems resulting in particular events
dominating such as procedures by nursing staff or nurse
witnessed AEs.27 28 Incident reports have thus been cri-
tiqued as ‘a non-random sample of identiﬁed hazards
from a larger unknown universe of hazards’.29
Another limitation to fulﬁlling the beneﬁts of AEs
using incident reporting alone is ‘the limited amount
and variable quality of the information found within
individual incident reports’.30 A perception also exists
among health professionals that only AEs with serious
outcomes should be reported. There is usually no oppor-
tunity for patients to contribute to information conveyed
through incident reporting thereby excluding their
knowledge and experience in models of routine incident
reporting. Our research will provide an understanding
of AEs through the patient’s own experience of AEs.
This focus will add an important dimension to current
clinical, health service and policy responses to AEs.
Open disclosure
Open disclosure is the requirement to provide honest
explanations to patients and families who have been
impacted by AEs. The requirement for open disclosure
has been formalised in Australian healthcare settings,
predominantly through endorsement of the National
Open Disclosure (OD) Standard in the different states
and territories.9
There is a paucity of evidence regarding the number
of AEs that are disclosed to patients; one study of mis-
takes by junior doctors reported a low 12% disclosure
rate of AEs to patients.31 A US survey found that only
one-third of patients who had experienced an AE had
been informed; but in another US study eliciting
patient-identiﬁed AEs, 40% reported disclosure (deﬁned
as a positive answer to the question: “Did anyone from
the hospital explain why the negative effects
occurred?”).32 33 Evidence suggests that disclosure of
AEs doubled the odds that patients would give higher
ratings to the quality of their care.20
Aim
The aim of this research is to investigate their experi-
ences of AEs and to identify data that can be used to
create more effective service and policy responses to
such events.
Objectives
1. To determine the patient experience of AEs, includ-
ing patients’ experience of information sharing (dis-
closure) after an AE and the role of patients in
reporting AEs.
2. To ascertain the frequency and characteristics of AEs
experienced by patients in hospitals located in the
state of NSW, Australia.
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3. To describe the characteristics of patients who experi-
ence AEs, in comparison to patients who do not
experience AEs.
4. To carry out a detailed examination of present
service and policy structures designed to deal with
AEs and make recommendations for change based
on our ﬁndings.
5. To undertake community consultation about the
ﬁndings and transfer project ﬁndings to the commu-
nity, policymakers, health practitioners and service
managers.
METHODS
Ethics approval
Ethics approval was granted by the NSW Population and
Health Services Research Ethics Committee (HREC/13/
CIPHS/66 &2013/12/496). It was agreed between the
two ethics committees that the latter ethics committee
would be the single committee managing and monitor-
ing the research.
Design
This is a mixed methods study involving data collection
via cross-sectional survey from a large research cohort,
interviews with high-level policymakers, and data linkage
between The Centre for Health Record Linkage
(CHeReL), the Admitted Patient Data Collection
(APDC), the Register of Births, Deaths and Marriages
(RBDM) and the 45 and Up Study databases.
Setting and participants
Study population -survey
The sample will be drawn from the 45 and Up Study
cohort. The 45 and Up Study is the largest cohort study
in the Southern Hemisphere, including 265 000 partici-
pants across NSW who are aged 45 and above. The study
completed recruitment in 2008 and all recruits have
consented to the use of their data in research. A wide
range of data is available on the 265 000 participants in
the 45 and Up Study cohort, including age, postcode,
education, ethnicity, lifestyle and habits, current medica-
tions, history of disease, surgical procedures and employ-
ment status.34 The choice to use an existing collection
of participants was made because the difﬁculty of
recruiting respondents through their health services is
well established.35 Advertising through the public media
does not necessarily attract a representative patient
population. Nor do hospital selected patients meet cri-
teria for an unbiased study cohort.
A primary beneﬁt of the 45 and Up sample is that it will
improve access to a general and guaranteed sample popu-
lation. Past efforts to research this topic have been ham-
pered by the difﬁculty of accessing an unbiased sample
population. Accessing the appropriate survey population
is an important consideration for this research. Because
the majority of patients hospitalised in Australia are over
45 the use of this study population is ideal.36
Furthermore, AEs tend to occur in older people. In one
Australian study (N=979 834), patients with an AE were
older (M=62.5, 95% CI 62.7 to 63 years) than those
without an AE (M=48.2, 95% CI 48.1 to 48.3 years).37 In
another Australian study (N=1177), age >70 years was
found to be a strong predictor (OR 1.9, 95% CI 1.3 to
2.6) of AEs following surgery.38 Our study participants
will be a random sample of 20 000 from the 45 and Up
Study cohort who were hospitalised at any hospital in
NSW over the most recent 6 month period to the time of
data collection. These participants will be identiﬁed
using data linkage provided by the Centre for Health
record Linkage (CHeReL) with the Admitted Patient
Data Collection, which is administered by NSW Health.
Limitations of survey sample
A recognised limitation of the 45 and Up Study is that it
is not representative with respect to individuals from cul-
turally and linguistically diverse (CALD) backgrounds.
For example, while only 25% of the 45 and Up Study
were born outside of Australia, 2006 census data puts this
ﬁgure at 39% for those aged 45 and above in NSW.36 In
order to address this limitation we will analyse a subset of
the surveys we receive from CALD participants to
compare the experiences of those CALD participants
who experienced an AE with those who did not experi-
ence an AE. We will also compare the CALD participants
in the 45 and Up cohort to the non-CALD members of
the cohort to see if there are speciﬁc differences or varia-
tions in the characteristics associated with the AE.
Survey sample size
We anticipate there to be 20 000 participants in the
cohort eligible to take part in the study based on the
number of participants within the cohort who have been
hospitalised. In a 6-month period ( July–December) in
2007, there were 18 460 public hospitalisations among
45 and Up Study participants. Hospitalisation rates will
rise every year as the cohort ages; thus, we estimate
20 000 public hospitalisations (our study population) for
the 6-month period January 2014–June 2014. We antici-
pate a 60% response rate to our questionnaire based on
the response rates observed in other substudies of 45
and Up participants, yielding an estimated 14 000
respondents. We expect approximately 3500 respondents
(25%) will have experienced an AE based on patient AE
self-reporting ﬁgures reported elsewhere; the remaining
10 500 respondents are expected not to have experi-
enced an AE and will be the control group.
Study population—interviews
We will conduct interviews with 30 individuals who have
a direct role in managing AEs and thereby holding
embodied knowledge about practice in the ﬁeld.
Sampling will be purposive, based on the roles that indi-
viduals fulﬁl. Participants will be initially identiﬁed by
the project reference group associated with the project
and subsequently through Clinical Governance Units of
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Local Health Networks. We expect to conduct around
30 interviews, including 10 working in policy settings
(with clinical governance managers working in govern-
ment policy and within key bodies such as the Australian
Commission on Safety and Quality in Health Care, NSW
Clinical Excellence Commission and the NSW Health
Care Complaints Commission) and 20 with individuals
working in practice settings (service managers, practi-
tioners working as complaints managers). We will pur-
posively seek to include a sample from two Metropolitan
Local Health Districts (Sydney, Western Sydney) and two
Rural and Regional NSW Local Health Districts (Far
West, Hunter New England). The ﬁnal number of inter-
views will be determined as the interviews progress.
Interviewing will be halted at the point of data saturation
once no new data are emerging.
Procedure
The study will run from July 2013 to July 2016 with data
collection starting November 2014. This study comprises
ﬁve phases:
1. Questionnaire development;
2. Completion of contractual arrangements with data
linkage partners;
3. Administration of questionnaire;
4. Analysis of survey responses;
5. Mapping of existing formal service and policy
responses to AEs;
6. Transfer of project ﬁndings to the policy and practice
community.39
Phase one—questionnaire development
In phase one, the survey for patients was developed and
reﬁned in a series of stages. Past patient experience
research was used to develop items to determine
whether patients experienced an AE and opportunities
for patients to report AEs (during care, discharge, post-
hospitalisation). Iedema et al11 (chief investigator B) and
Weingart et al’s40 surveys of patient experiences of open
disclosure were a signiﬁcant foundation of data for the
development of these items.5 We included the Picker
Adult Inpatient Questionnaire (PAIQ) which is a vali-
dated questionnaire designed to elicit patients’ overall
hospital experiences about their care and treatment.41 It
has a high degree of face validity, construct validity and
internal reliability consistency.41 Items about open dis-
closure and subsequent decision making about com-
plaint or litigation were also incorporated. A validated
instrument for assessing open disclosure by CI Iedema
was used to assess the quality of formal open disclosure
against new national indicators. Items from this instru-
ment along with that used by Weingart in the USA were
used to identify what information was provided about
the AE; what action was taken to remedy the situation;
what did not happen; intention of making a formal com-
plaint or of seeking compensation; areas not addressed
that the patient wanted addressed. We also included
items to determine where and when the AE(s) occurred
(ie, public/private hospitals, in/out NSW, within correct
time-frame parameters etc in order to identify possible
confounding variables). An expert panel reviewed
several iterations of the survey to attend to issues such as
length, content validity, scaling responses and potential
for response bias.
The resulting survey comprises ﬁve parts A–E. Part A
asks patients for details of their hospitalisation followed
by an additional four further validated sections. Part B
incorporates questions about care and treatment from
the validated Picker questionnaire.41 Part C includes a
series of items regarding the healthcare incident based
on Weingart et al.5 40 Part D asks about experiences of
disclosure based on work by Iedema et al.11 Part E
explores patient reports based on items developed by
Daniels and also work by Walton et al (chief investigator
A).42 The survey was reviewed by the Project Reference
Group for suitability and face validity and approved by
the 45 and Up Study Management Committee.
Phase two—questionnaire administration
Phase 2 will include administration of the questionnaire
to a sample of recently hospitalised patients from the 45
and Up data bank. The Centre for Health Record
Linkage (CHeReL) is a NSW Ministry of Health
Agency.43 CHeReL will link data from the Admitted
Patient Data Collection with the 45 and Up Study
Database to identify participants who have been hospita-
lised in the 6-month period between January and June
2014 using admission data. A random sample of 20 000 of
the eligible 45 and Up participants will be sent a survey
pack by the mailing house including an invitation letter, a
participant information leaﬂet and the survey with a per-
forated consent form attached to it. In keeping with
other studies of the 45 and Up participants, CALD or any
other participants who have difﬁculty reading in English
are advised to seek help from a friend or relative to
understand the study materials and to complete the
survey. Those who wish to participate are required to
complete the consent form and return with their com-
pleted survey to the 45 and Up Study using the reply-paid
envelope included in the pack. Participants who have not
experienced an AE will only complete parts A and B of
the survey, providing details about their hospital stay and
their experience of this stay. Participants who have experi-
enced an AE will complete a further three parts (C, D
and E) in which they will answer questions about the AE,
the Open Disclosure process and whether they made a
complaint. Returned surveys will be screened by the 45
and Up Study team to ensure the consent form is com-
plete and then sent on to the research team in a
de-identiﬁed form for analysis. Any surveys with no
signed consent form will not be included.
Phase three—analysis of questionnaire data
Phase 3 will involve qualitative and quantitative data
analysis of completed questionnaires to obtain
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comprehensive information on patient characteristics,
the nature and frequency of any AEs experienced and
the impact of AEs on patient outcomes, whether the
patient experienced an Open Disclosure process
(formal or informal) and whether the patient made a
complaint or initiated legal action.
Qualitative analysis
Two analyses of qualitative questionnaire data will be
performed:
The conceptual framework of the International
Classiﬁcation for Patient Safety will be employed.42 The
International Classiﬁcation for Patient Safety categorises
patient safety information using standardised sets of con-
cepts to facilitate ‘description, comparison, measurement,
monitoring, analysis and interpretation of information to
improve patient care, and for epidemiological and health
policy planning purposes’ (ref. 44, p.1). Each AE incident
will be independently classiﬁed by two safety experts.
Using the method devised by Runciman et al 45 ‘natural
categories’ will be determined and contributing factors,
detection, mitigating factors, patient and organisational
outcomes and ameliorating factors will be sought. The
comments that patients make about their AE will be
examined and thematically coded using discourse analysis
as this has been effectively used for analysing patient
experience in previous research.46 The analysis will be
structured around the research questions. NVivo will be
utilised to manage and track the discourse analytical
process that is applied to the data. Patient identiﬁed
opportunities for reporting AEs will also be examined
and thematically coded, paying special attention to the
type of AE, location in the hospital, age group, cultural
background and the opportunities to report.47
Quantitative analysis
Estimates of the frequency and type of AE identiﬁed
from questionnaire results will be conducted. The use of
the WHO International Classiﬁcation for Patient Safety
to categorise patients’ descriptions of their AEs will
ensure that foreseeable and known complications of
conditions and treatments are separately identiﬁed and
described. Patient experiences that fall outside the classi-
ﬁcation system will be identiﬁed and explored.
Descriptive statistics (eg, means, SDs, frequencies and
percentages) will be calculated to summarise data col-
lected. In particular, estimates of the frequency and type
of AE will be estimated with 95% CIs. Logistic regression
will be used to determine if patients who experience
AEs differ from patients who do not experience AEs.
Potential risk factors will focus on patient characteristics
such as age; gender; region; chronic disease(s), length
of stay, transfer to other healthcare services. Other
factors may be identiﬁed through the conceptual frame-
work noted above. Appropriate model building strategies
and model checking will be employed.48
Phase 4—mapping of existing service and policy responses
In phase 4 we will analyse existing service and policy
responses to AEs by undertaking a mapping exercise,
combining data from a detailed document mapping
exercise and interviews with key actors in the ﬁeld. The
results of this analysis to make detailed recommenda-
tions about how these service and policy structures can
best make use of the patient experience data. This
mapping is an important component of the research
project because government organisations are mandated
to implement processes related to AEs. An understand-
ing of current practice will allow our recommendations
to ﬁt into and build on existing practice.
Stakeholder interviews: Interviews will be semistruc-
tured and open-ended. Questioning will focus on
present service and policy structures designed to deal
with AEs and the extent to which patient experiences
are utilised as a source of knowledge in service and
policy design. Participants will also be asked which docu-
ments they draw on in their work. They will be con-
tacted directly via email and asked to participate in an
interview which will take place at their place of work, or
by phone if they prefer. Interviews will be recorded with
the participant’s permission and transcribed.
Interview Data Analysis: Data will be hand coded
through the qualitative data analysis software NVivo.
Thematic analysis will be conducted based around the
project research aims. Coding reliability will be improved
through independent coding of a subsample of the
interviews by different members of the research team.
Initial thematic codes from all interviews will be brought
together and recoded to draw out subcodes. Individual
sections of the data will be freshly coded to ensure an
alignment between initial and later coding. Single
instances of codes will be removed and those with close
similarity to other codes will be merged. A narrative of
the themes derived from the coding will be created.
Representative quotations will be selected to demon-
strate the themes where necessary.
Document Analysis: The aim of the documentary ana-
lysis will be to ﬁnd and summarise the formal docu-
ments which structure practice around AEs. Health
department policies, Guidelines distributed by Local
Health Districts, quality and safety protocols published
by the NSW Clinical Excellence Commission and the
Australian Commission on Quality and Safety will be
identiﬁed through a range of approaches: (1) literature
review—by locating any formal documents cited by aca-
demic sources; (2) reference group—through sugges-
tions made by the project research group; (3) interview
respondents—through locating any documents spoken
about in the interviews. Documents will be summarised
according to purpose and audience.
Phase 5—transfer of research findings.
Phase 5 will involve transfer of ﬁndings to the commu-
nity, policymakers, service managers and agencies. We
Walton M, et al. BMJ Open 2014;4:e006599. doi:10.1136/bmjopen-2014-006599 5
Open Access
will seek feedback from the community about opportun-
ities to contribute to AE reporting.
The analysed results from phases 1 to 3 that relate to
patients’ perceptions and suggestions will form the basis
of the community consultation. We will hold a 1-day
workshop based on the WHO Patients for Patient Safety
Workshop model. This model brings together commit-
ted patients and family members from rural and metro-
politan areas to establish a network of champions, many
of whom were nominated by health regions or other
healthcare organisations who see them as partners in
improving patient safety.
Project advisory committee
A reference group of key stakeholders including repre-
sentatives from patient safety agencies, consumers, policy-
makers and service providers has been convened to assist
the research team from the inception of the project. The
group includes representatives from the Sax Institute,
the Clinical Excellence Commission, the Australian
Commission for Safety and Quality in Health Care,
Health Consumers NSW and the North Sydney Local
Health District. This spectrum of members provides a
diverse range of perspectives on the project topic and
proposed methods to be employed which are discussed at
bi-annual reference group meetings.
DISCUSSION
Project outcomes
The results of this study will have a profound impact on
the management of AEs in Australian hospitals and add
to international knowledge on AEs. For the ﬁrst time we
will have comprehensive evidence to enable health
departments, practitioners, health educators and the
community to understand the impact of AEs on
patients.
Achieving the ﬁve study objectives will result in a
number of important outcomes. Evidence of the patient
experience of their hospitalisation will be useful in the
development of policy and will assist practitioners to
change practice or introduce new activities to reduce
AEs. We will obtain a proﬁle of patients who self-report
an AE. This proﬁle will enable future identiﬁcation of
groups at risk of AEs (such as age, gender, time of
admission, cultural and language background,
comorbidities) for the development of targeted safety
strategies, including health service design, education
and training of health clinicians. A map of the incidence
and characteristics of AEs as reported by patients will
assist the development of targeted programmes to
reduce AEs.
We will provide insight into patient reactions to the
process of information sharing that will be highly inﬂu-
ential for reviews of communication processes and open
disclosure guidelines across Australia. This is highly rele-
vant information for practising clinicians in the health
system as well as governments and indemnity insurers
and those engaged in curriculum development and
community education. Detailed policy and service
recommendations will use our study data to enhance
existing governance structures around AEs. Our work
will also facilitate assessment of whether there are oppor-
tunities for patients to play a greater role in reporting
AEs and how this could be realised. Finally, this work
will produce a greater awareness within the health
system and the community more broadly about the
impact of AEs on patients. This project is also the ﬁrst
that we are aware of to use data from patient medical
records to explore AEs. Using linked data, we will be
able to triangulate patient reports with the content of
their medical records and identify the extent of congru-
ence between these information sources.
Ethics and dissemination
The 45 and Up Study cohort consent to their 45 and Up
Study baseline data being linked with the Admitted
Patient Data Collection; using linked data in this way to
identify recently hospitalisation 45 and Up Study partici-
pants does not pose any ethical concerns. The cohort
also consents to being contacted for health-related
research and appropriate ethical approval has been
obtained to approach these participants. Dissemination
of ﬁndings to key stakeholders is a critical feature of the
study protocol in order to support the community,
health service providers and policymakers to develop
more effective responses to AEs in patient care. In phase
5 of the study we will transfer ﬁndings to the community,
policymakers, service managers and relevant agencies.
This process includes a 1-day workshop based on the
WHO Patients for Patient Safety Workshop model. We
will also produce peer-reviewed publications and present
ﬁndings at national and international conferences.
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